-
1دورية أكاديمية
المؤلفون: Wen Yan, Chi‐Yeh Chung, Tao Xie, Mark Ozeck, Timothy C. Nichols, Jessica Frey, Akshata R. Udyavar, Shikhar Sharma, Thomas A. Paul
المصدر: Molecular Oncology, Vol 16, Iss 6, Pp 1309-1328 (2022)
مصطلحات موضوعية: drug resistance, epigenetic therapy, KDM1A, LSD1, small‐cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Mélanie Desbois, Akshata R. Udyavar, Lisa Ryner, Cleopatra Kozlowski, Yinghui Guan, Milena Dürrbaum, Shan Lu, Jean-Philippe Fortin, Hartmut Koeppen, James Ziai, Ching-Wei Chang, Shilpa Keerthivasan, Marie Plante, Richard Bourgon, Carlos Bais, Priti Hegde, Anneleen Daemen, Shannon Turley, Yulei Wang
المصدر: Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
مصطلحات موضوعية: Science
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2041-1723Test
-
3دورية أكاديمية
المؤلفون: Anneleen Daemen, Akshata R. Udyavar, Thomas Sandmann, Congfen Li, Linda J. W. Bosch, William O’Gorman, Yijin Li, Amelia Au-Yeung, Chikara Takahashi, Omar Kabbarah, Richard Bourgon, Priti Hegde, Carlos Bais, Meghna Das Thakur
المصدر: PLoS ONE, Vol 16, Iss 12 (2021)
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Chan Whiting, Ping Fang, Kyle Cron, Sara Tribble, Hailey He, Christopher Thanos, Oanh Pham, Julie Janes, John Brandenburg, Emily Miyashita-Lin, Omkar Joshi, Akshata R Udyavar
المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2051-1426Test
-
5دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort
-
6دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort
-
7دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort
-
8دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort
-
9دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort
-
10دورية أكاديمية
المؤلفون: Anneleen Daemen (365394), Akshata R. Udyavar (11890792), Thomas Sandmann (36795), Congfen Li (11890795), Linda J. W. Bosch (9620795), William O’Gorman (7374848), Yijin Li (7538720), Amelia Au-Yeung (6801554), Chikara Takahashi (6801557), Omar Kabbarah (248530), Richard Bourgon (74522), Priti Hegde (7374851), Carlos Bais (11890798), Meghna Das Thakur (11890801)
مصطلحات موضوعية: Cell Biology, Genetics, Molecular Biology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, year survival rate, targeted treatment evaluation, provides scientific rationale, included 1062 patients, consensus molecular subtypes, cms2 tumor cells, biomarker defined subpopulations, propagates stage ii, disease 8217, adjuvant stage ii, validation cohort gse39582, immune 8212, high granzyme b, disease specific role, accurately capture high, significant prognostic impact, cell independent fashion, cancer genome atlas, alternative gzmb source, performed expression profiling, risk crc patients, independent cohort